HOME >> MEDICINE >> NEWS
Genetics in clinical practice: a revolutionary approach

l resident, ordering a genetics test for a patient is not like ordering a standard test, such as for cholesterol. There is not only the science, but the associated psychosocial aspects. It's one thing to know about the genetics, for example of cystic fibrosis, but it's another thing to counsel a couple who are pregnant with a child who may be affected by CF," says Henderson. This program offers that real-world aspect by virtual interaction and exposure to patients.

The program's flow and content centers on three simulated patients who have, or are at risk of developing, diseases for which knowledge of clinical genetics can affect outcomes. In some instances, patient outcomes will depend on the management decisions and other actions of the learner. The highly detailed, computer-based environment is intuitive and easy to use any time, any place via a broadband Internet connection or on a CD. The CD will be available to outside users through professional organizations such as the American College of Medical Genetics and at little or no cost to the Dartmouth community.

The program is intended for health care providers who may see patients with disorders--or who have concerns about disorders--for which clinical genetics knowledge can positively impact outcomes. It addresses three central topics: genetics in clinical practice, working with genetics labs and lab workers and working with genetic counselors, and may also be helpful in training students, genetic counselors, medical laboratory professionals, public health practitioners and others interested in genetic testing. Users participate in a "virtual mini-fellowship" with a master clinician/master teacher.

IML specializes in combining emerging technology with innovative instructional design, producing high-end interactive multimedia educational programs for both patients and health care providers and develops distance learning systems capable of delivering multimedia over the Internet. The genetics virtu
'"/>

Contact: DMS Communications
dms.communications@dartmouth.edu
603-650-1492
Dartmouth Medical School
15-Aug-2002


Page: 1 2 3

Related medicine news :

1. Genetics important in age-related macular degeneration
2. Genetics testing saves health care dollars
3. Genetics of familial atrial fibrillation revealed, Science researchers report
4. Genetics likely to be a major factor in osteoarthritis of the hip
5. Fred Hutchinson Cancer Research Center And Targeted Genetics Corp. Publish Data On Adoptive Immunotherapy For HIV
6. British hospitals need clinical ethicists
7. Lack of clinical trial participation may contribute to lower survival rates
8. Obtaining patient consent for clinical audit is unworkable without extra resources
9. Sharing clinical trial results with participants may be beneficial
10. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
11. PENN begins clinical trial of newest technology to treat thoracic aortic aneurysms

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Genetics clinical practice revolutionary approach

(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... The Jerry ... at The ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over ... raised more than $13.5 million for programs and services designed to support patients and ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... the release of version 5.2 of the FirstSpirit Content Management System with new ... With the new version of FirstSpirit, companies will be well on their way ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the Massachusetts-based charity ... (FSHD), will be the beneficiary of a collection of fundraising events this fall. From ... of the FSH Society and further FSHD research. , The list of ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... and Qualification of Laboratory Instruments in accordance with GMP requirements“ , featuring Ed ... on October 6th, 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, ...
(Date:9/1/2015)... York, NY (PRWEB) , ... September 01, 2015 ... ... that, to date, more than 1,500 investor-families have received permanent green cards (I-829 ... EB-5 projects. , The I-829 petition is the final step of the EB-5 ...
Breaking Medicine News(10 mins):Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2
(Date:9/1/2015)... , Sept. 1, 2015  Abbott (NYSE: ABT ... a multi-center, randomized trial comparing the safety and effectiveness ... ® , Abbott,s market-leading, permanent drug eluting stent. ... Japan and enrolled 400 people with ... disease. The results will be featured at a late-breaking ...
(Date:9/1/2015)... , Sept. 1, 2015  Valeant Pharmaceuticals International, ... today announced that its affiliate has entered into ... was granted an exclusive license to develop and ... IL-17 receptor monoclonal antibody in development for patients ... the agreement, Valeant will hold the exclusive rights ...
(Date:8/31/2015)... Pepperl+Fuchs, a world leader in process ... leading provider of HART protocol devices. The move ... its integrated solutions offerings and strengthen its position ... are pleased to add the MACTek WirelessHART product ... Bolin , Pepperl+Fuchs, executive vice president of the ...
Breaking Medicine Technology:Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
Cached News: